ARTICLE | Clinical News
Toviaz fesoterodine regulatory update
May 11, 2015 7:00 AM UTC
FDA granted tentative approval to an ANDA from Amerigen Pharmaceuticals Ltd. (Lyndhurst, N.J.) for a generic version of Toviaz fesoterodine to treat overactive bladder (OAB). Pfizer has exclusive, wo...